Home » Newsletters » BioWorld

BioWorld

Oct. 5, 1994

View Archived Issues

DARWIN MOLECULAR COULD GET $16.5M FROM RHONE- POULENC

BTG PLACES SHARES, LOSES PAYMENT

SUGEN COMPLETES IPO, NETS $18M

SEPRACOR PLACEMENT RAISES $5M

`MAGIC BULLET' REVISITED INTERFERON MAKING COMEBACK AS POTENTIAL

INTERLEUKIN ADJUVANTS ADVANCE TO NEW HUMAN TRIALS

ZYNAXIS CUTS STAFF 25 PERCENT IN RESTRUCTURING EFFORT

PHASE II RESULTS OF BRADYCOR POSITIVE FOR HEAD TRAUMA

ANOTHER DAVID BLECH CASUALTY . . . PARNASSUS LAYS OFF ITS WORK FORCE,

IMMUNOLOGISTS UPBEAT AT START OF CANCER VACCINE SYMPOSIUM